<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02274974</url>
  </required_header>
  <id_info>
    <org_study_id>local infilteration of C.S</org_study_id>
    <nct_id>NCT02274974</nct_id>
  </id_info>
  <brief_title>Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine</brief_title>
  <official_title>Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine;Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to compare between efficacy of post-caesarean section infiltration with lidocaine and
      epinephrine versus lidocaine only to reduce post-incisional pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      assessment of adding of epinephrine to lidocaine as local infiltrator to post-caesarean
      section wound in prolongation of its anaesthetic effect.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Timing of first analgesic request.</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of cesarean section</measure>
    <time_frame>30 min to 90 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of breast breastfeeding</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of mobilization</measure>
    <time_frame>24 hours</time_frame>
    <description>first time patient start moving after the section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>24 hours to 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects of local infiltration of lidocaine and epinephrine</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pyrexia</measure>
    <time_frame>24 hours</time_frame>
    <description>&lt;38°c</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 ml of 2% lidocaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine and epinephrine.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 ml of 2% lidocaine and epinephrine in related dose manner 1:200.000. I.e.: by adding 1/4 from ampoule of adrenaline 1mg./1ml to bottle of lidocaine Hydrochloric acid (HCL) 2% 50 ml(20mg/ml).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>•The wound of C.Swill be infiltrated before closure of the skin, with 20 ml of 2% lidocaine.</description>
    <arm_group_label>lidocaine</arm_group_label>
    <other_name>local anaesthetic agent.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine and Epinephrine</intervention_name>
    <description>The wound of C.S will be infiltrated before closure of the skin, with 20 ml of 2% lidocaine and epinephrine in related dose manner 1:200.000.</description>
    <arm_group_label>lidocaine and epinephrine.</arm_group_label>
    <other_name>local anaesthetic agent.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing caesarean delivery under General anesthesia for various indications.

          -  Women refuse spinal anesthesia.

        Exclusion Criteria:

          -  Known or suspected sensitivity to local anesthesia.

          -  Medical disorders induced by pregnancy (Pre-eclamptic toxemia, gestational diabetes
             mellitus, Hepatic diseases, homeostatic disorder)

          -  Medical disorders aggravated by pregnancy (cardiovascular disease, pulmonary disease,
             renal disease, neurological disease, metabolic or infectious diseases).

          -  Women who hemo-dynamically unstable.

          -  Lack of adequate verbal communication.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr H Yhia, M.D, MRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams Maternity Hospital(AinShamsMH)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine;</name>
      <address>
        <city>Cairo</city>
        <zip>11511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Tharwat AA, Yehia AH, Wahba KA, Ali AE. Efficacy and safety of post-cesarean section incisional infiltration with lidocaine and epinephrine versus lidocaine alone in reducing postoperative pain: A randomized controlled double-blinded clinical trial. J Turk Ger Gynecol Assoc. 2016 Jan 12;17(1):1-5. doi: 10.5152/jtgga.2015.0185. eCollection 2016.</citation>
    <PMID>27026771</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2014</study_first_submitted>
  <study_first_submitted_qc>October 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2014</study_first_posted>
  <last_update_submitted>June 24, 2015</last_update_submitted>
  <last_update_submitted_qc>June 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>AMR HELMY YEHIA</investigator_full_name>
    <investigator_title>Lecturer in Obstetrics and Gynaecology</investigator_title>
  </responsible_party>
  <keyword>incisional</keyword>
  <keyword>infiltration</keyword>
  <keyword>cs</keyword>
  <keyword>lidocaine</keyword>
  <keyword>epinephrine</keyword>
  <keyword>Adverse Reaction to Topical or Infiltrative Lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

